Literature DB >> 19596313

Morphologic indicators predict the stage of chromatin condensation of human germinal vesicle oocytes recovered from stimulated cycles.

Laura Escrich1, Noelia Grau, Marcos Meseguer, Antonio Pellicer, María-José Escribá.   

Abstract

OBJECTIVE: To assess germinal vesicles (GV) recovered from stimulated cycles by means of morphometric and morphologic examination (using contrast-phase and image analysis) and chromatin configuration (using fluorescent DNA imaging), and to evaluate the relevance of morphometric and morphologic parameters as forecasters of chromatin status.
DESIGN: Experimental study.
SETTING: University-affiliated infertility clinic. PATIENT(S): One hundred and thirty-one GV oocytes donated to patients for intracytoplasmic sperm injection. INTERVENTION(S): We evaluated 131 GVs by means of morphology and morphometry with the use of contrast phase microscopy. They were subsequently fixed, DNA stained, and assessed by fluorescent microscopy. Compiled data were retrospectively grouped according to three models. MAIN OUTCOME MEASURE(S): Model A: ova were grouped according to chromatin condensation (noncondensed vs. condensed). Model B: ova were grouped according to chromatin distribution in relation to the nucleolus-like body (NLB) (not surrounding vs. surrounding and/or absent) but regardless of the condensation stage. Model C: GV oocytes were grouped according to the combination of both of the previously mentioned parameters (chromatin condensation and distribution in relation to the NLB). RESULT(S): According to the GV classification of model A, nucleoplasm, nucleus position, nuclear envelope continuity, and oocyte size were shown to be relevant and were included in a mathematical model for predicting chromatin condensation stage. CONCLUSION(S): Noninvasive analysis of GV oocytes using contrast-phase microscopy maintains oocytes in a viable state and allows the chromatin condensation status to be predicted. Copyright 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596313     DOI: 10.1016/j.fertnstert.2009.05.077

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  The competence of germinal vesicle oocytes is unrelated to nuclear chromatin configuration and strictly depends on cytoplasmic quantity and quality in the cat model.

Authors:  P Comizzoli; B S Pukazhenthi; D E Wildt
Journal:  Hum Reprod       Date:  2011-06-10       Impact factor: 6.918

2.  Spontaneous in vitro maturation and artificial activation of human germinal vesicle oocytes recovered from stimulated cycles.

Authors:  Laura Escrich; Noelia Grau; Amparo Mercader; Carmen Rubio; Antonio Pellicer; María-José Escribá
Journal:  J Assist Reprod Genet       Date:  2010-10-22       Impact factor: 3.412

Review 3.  Follicle environment and quality of in vitro matured oocytes.

Authors:  Marc-André Sirard
Journal:  J Assist Reprod Genet       Date:  2011-03-11       Impact factor: 3.412

Review 4.  Contribution of human oocyte architecture to success of in vitro maturation technology.

Authors:  Mohammad Ali Khalili; Stefania A Nottola; Abbas Shahedi; Guido Macchiarelli
Journal:  Iran J Reprod Med       Date:  2013-01

Review 5.  Heterochromatin Morphodynamics in Late Oogenesis and Early Embryogenesis of Mammals.

Authors:  Irina Bogolyubova; Dmitry Bogolyubov
Journal:  Cells       Date:  2020-06-19       Impact factor: 6.600

6.  Synthesis and In Vitro Antitumor Activity of Novel Bivalent β-Carboline-3-carboxylic Acid Derivatives with DNA as a Potential Target.

Authors:  Hongling Gu; Na Li; Jiangkun Dai; Yaxi Xi; Shijun Wang; Junru Wang
Journal:  Int J Mol Sci       Date:  2018-10-15       Impact factor: 5.923

7.  The Relationship between Cell Number, Division Behavior and Developmental Potential of Cleavage Stage Human Embryos: A Time-Lapse Study.

Authors:  Xiangyi Kong; Shuting Yang; Fei Gong; Changfu Lu; Shuoping Zhang; Guangxiu Lu; Ge Lin
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.